Prophylactic role of tixagevimab/cilgavimab for COVID-19 in newly transplanted kidney recipients: Single-center experience and review of literature

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-2)

Sum=12

Publishing Process of This Article

Item

Count

Browse

Download

Sum=0

Dec 18, 2025 (publication date) through Nov 19, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Transplant. Dec 18, 2025; 15(4): 100041
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.100041

Figure 1 PRISMA flowchart for literature review.

Citation: El Chediak A, Ahuja D, Bruns C, Simard R, Spence K, Gul A, Forbes RC, Concepcion BP. Prophylactic role of tixagevimab/cilgavimab for COVID-19 in newly transplanted kidney recipients: Single-center experience and review of literature. World J Transplant 2025; 15(4): 100041
URL: https://www.wjgnet.com/2220-3230/full/v15/i4/100041.htm
DOI: https://dx.doi.org/10.5500/wjt.v15.i4.100041